[1] Galderisi U, Giordano A. The gap between the physiological and therapeutic roles of mesenchymal stem cells. Med Res Rev. 2014;34(5):1100-1126.[2] Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131(2):324-336.[3] Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 2010; 28(3):585-596.[4] Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130(8):1715- 1725.[5] Wagner W, Horn P, Castoldi M, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3(5):e2213.[6] Qiu Z, Li X. Non-human Primate Models for Brain Disorders - Towards Genetic Manipulations via Innovative Technology. Neurosci Bull. 2017;33(2):247-250.[7] Tadin-Strapps M, Robinson M, Le Voci L, et al. Development of lipoprotein(a) siRNAs for mechanism of action studies in non-human primate models of atherosclerosis. J Cardiovasc Transl Res. 2015;8(1):44-53.[8] Peña JC, Ho WZ. Non-Human Primate Models of Tuberculosis. Microbiol Spectr. 2016;4(4):1-2.[9] Sasaki E. Prospects for genetically modified non-human primate models, including the common marmoset. Neurosci Res. 2015;93:110-115.[10] 邵海涛,张连峰.肝素结合性表皮生长因子在心肌重塑中的作用[J].中国比较医学杂志, 2011, 21(6):80-84.[11] Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta. 1997;1333(3):F179-199.[12] 罗金龙,姜淮芜.胎盘生长因子与肿瘤的研究进展[J].现代生物医学进展, 2013,13(6):1176-1179.[13] Konstantina A, Lazaris AC, Ioannidis E, et al. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi. Melanoma Res. 2011;21(5):389-394.[14] Alpini G, Glaser SS, Zhang JP, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol. 2011;55(6):1339-1345.[15] Wei SC, Tsao PN, Yu SC, et al. Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut. 2005;54(5):666-672.[16] Li Y, Xu X, Wang L, et al. Senescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression. Cell Biosci. 2015;5:21.[17] 宁雪,李栋,汪大琨,等.脐带间充质干细胞体外衰老过程中生物学特性及基因表达谱的变化[J].中国实验血液学杂志, 2012, 20(2): 458-465.[18] Yang C, Przyborski S, Cooke MJ, et al. A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells. 2008;26(4):850-863.[19] Liu TM, Ng WM, Tan HS, et al. Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev. 2013; 22(2):268-278.[20] Tsai CC, Chen CL, Liu HC, et al. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci. 2010;17:64.[21] Li S, Bian H, Liu Z, et al. Chlorogenic acid protects MSCs against oxidative stress by altering FOXO family genes and activating intrinsic pathway. Eur J Pharmacol. 2012;674(2-3): 65-72.[22] Park KJ, Kim YJ, Kim J, et al. Protective effects of peroxiredoxin on hydrogen peroxide induced oxidative stress and apoptosis in cardiomyocytes. Korean Circ J. 2012;42(1): 23-32.[23] Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications. Ageing Res Rev. 2009;8(2):94-112.[24] Zhang DY, Wang HJ, Tan YZ. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS One. 2011; 6(6):e21397.[25] Ocampo A, Reddy P, Martinez-Redondo P, et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell. 2016;167(7):1719-1733. |